The Motley Fool··Motley Fool StaffPsychedelic Therapy Emerges as Disruptive Mental Health Treatment Model
Psychedelic therapy advances as clinical treatment for depression and PTSD, with companies like Compass Pathways pursuing FDA approvals. The investment opportunity centers on $10,000-$20,000 treatment services rather than drugs.
JNJABBVCMPStreatment-resistant depressionpsilocybin